Paradigm Asset Management’s GSK GSK Stock Holding History

Paradigm Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,300	Closed	-$63.8K	–	433
2025 Q4	$63.8K	Hold	1,300	–	–	0.01%	382
2025 Q3	$56.1K	Hold	1,300	–	–	0.01%	382
2025 Q2	$49.9K	Hold	1,300	–	–	0.01%	395
2025 Q1	$50.4K	Hold	1,300	–	–	0.01%	401
2024 Q4	$44K	Sell	1,300 -200	-13%	-$7.2K	0.01%	405
2024 Q3	$61.3K	Sell	1,500 -300	-17%	-$12.3K	0.02%	376
2024 Q2	$69.3K	Hold	1,800	–	–	0.02%	363
2024 Q1	$77.2K	Hold	1,800	–	–	0.02%	373
2023 Q4	$66.7K	Hold	1,800	–	–	0.02%	380
2023 Q3	$65.3K	Buy	1,800 +800	+80%	+$28.4K	0.02%	387
2023 Q2	$35.6K	Hold	1,000	–	–	0.01%	439
2023 Q1	$35.6K	Hold	1,000	–	–	0.01%	426
2022 Q4	$35.1K	Hold	1,000	–	–	0.01%	443
2022 Q3	$29.4K	Buy	+1,000	New	+$37.9K	0.01%	410

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Paradigm Asset Management's GSK Position: Q1 2026 in Review

Paradigm Asset Management sold out of GSK (GSK) in Q1 2026, closing a stake of 1,300 shares — an estimated $63.8K sold.

Paradigm Asset Management first reported a position in GSK in Q3 2022 and held it in 14 quarters. The position peaked at $77.2K in Q1 2024. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Paradigm Asset Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Paradigm Asset Management sold 1,300 GSK shares in Q1 2026, an estimated $63.8K.
Paradigm Asset Management first reported a position in GSK in Q3 2022 and held it in 14 quarters.
Paradigm Asset Management's GSK position peaked at $77.2K in Q1 2024.
1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.